These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17159154)

  • 21. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
    Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
    Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of TRAK1 (Trafficking protein, kinesin-binding 1) as MGb2-Ag: a novel cancer biomarker.
    Zhang F; Ren G; Lu Y; Jin B; Wang J; Chen X; Liu Z; Li K; Nie Y; Wang X; Fan D
    Cancer Lett; 2009 Feb; 274(2):250-8. PubMed ID: 18986759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BigH3 protein expression as a marker for breast cancer.
    Calaf GM; Echiburú-Chau C; Zhao YL; Hei TK
    Int J Mol Med; 2008 May; 21(5):561-8. PubMed ID: 18425347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
    Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic analysis of p16ink4a-binding proteins.
    Souza-Rodrígues E; Estanyol JM; Friedrich-Heineken E; Olmedo E; Vera J; Canela N; Brun S; Agell N; Hübscher U; Bachs O; Jaumot M
    Proteomics; 2007 Nov; 7(22):4102-11. PubMed ID: 17955473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis.
    Katz-Brull R; Seger D; Rivenson-Segal D; Rushkin E; Degani H
    Cancer Res; 2002 Apr; 62(7):1966-70. PubMed ID: 11929812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX.
    Li S; Xu H; Ding H; Huang Y; Cao X; Yang G; Li J; Xie Z; Meng Y; Li X; Zhao Q; Shen B; Shao N
    J Pathol; 2009 Jul; 218(3):327-36. PubMed ID: 19291713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Distribution of actin isoforms in normal, dysplastic, and tumorous human breast cells].
    Dugina VB; Chipysheva TA; Ermilova VD; Gabbiani D; Chaponnier C; Vasil'ev IuM
    Arkh Patol; 2008; 70(2):28-31. PubMed ID: 18540438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Observation of multiple isoforms and specific proteolysis patterns of proliferating cell nuclear antigen in the context of cell cycle compartments and sample preparations.
    Naryzhny SN; Lee H
    Proteomics; 2003 Jun; 3(6):930-6. PubMed ID: 12833516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression and function of IGFBP-3 in normal and malignant breast tissue.
    McCarthy K; Laban C; McVittie CJ; Ogunkolade W; Khalaf S; Bustin S; Carpenter R; Jenkins PJ
    Anticancer Res; 2009 Oct; 29(10):3785-90. PubMed ID: 19846909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ubiquitylation of proliferating cell nuclear antigen and recruitment of human DNA polymerase eta.
    Nikolaishvili-Feinberg N; Jenkins GS; Nevis KR; Staus DP; Scarlett CO; Unsal-Kaçmaz K; Kaufmann WK; Cordeiro-Stone M
    Biochemistry; 2008 Apr; 47(13):4141-50. PubMed ID: 18321066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive cribriform breast carcinomas in patients with grade 1 and stage IIA (T2 N0 M0) breast cancer strongly express the v3 and v6, but not the v4 isoforms of the metastatic marker CD44.
    Saleh F; Reno W
    Neoplasma; 2008; 55(3):246-55. PubMed ID: 18348657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
    Monsef N; Soller M; Isaksson M; Abrahamsson PA; Panagopoulos I
    Prostate; 2009 Jun; 69(9):909-16. PubMed ID: 19274762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
    Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
    Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human breast cancer cells contain an error-prone DNA replication apparatus.
    Sekowski JW; Malkas LH; Schnaper L; Bechtel PE; Long BJ; Hickey RJ
    Cancer Res; 1998 Aug; 58(15):3259-63. PubMed ID: 9699652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Peptide mimicking a region in proliferating cell nuclear antigen specific to key protein interactions is cytotoxic to breast cancer.
    Smith SJ; Gu L; Phipps EA; Dobrolecki LE; Mabrey KS; Gulley P; Dillehay KL; Dong Z; Fields GB; Chen YR; Ann D; Hickey RJ; Malkas LH
    Mol Pharmacol; 2015 Feb; 87(2):263-76. PubMed ID: 25480843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA.
    Gu L; Lingeman R; Yakushijin F; Sun E; Cui Q; Chao J; Hu W; Li H; Hickey RJ; Stark JM; Yuan YC; Chen Y; Vonderfecht SL; Synold TW; Shi Y; Reckamp KL; Horne D; Malkas LH
    Clin Cancer Res; 2018 Dec; 24(23):6053-6065. PubMed ID: 29967249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer type-specific tNOX isoforms: A putative family of redox protein splice variants with cancer diagnostic and prognostic potential.
    Morré DJ; Hostetler B; Weston N; Kim C; Morré DM
    Biofactors; 2008; 34(3):201-7. PubMed ID: 19734121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.